Viewing Study NCT06250959


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-04-05 @ 8:37 AM
Study NCT ID: NCT06250959
Status: RECRUITING
Last Update Posted: 2024-04-04
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
Sponsor: Chen Suning
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module